189 related articles for article (PubMed ID: 22836862)
1. Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis.
Amin S; Lucas AL; Frucht H
Pancreas; 2013 Mar; 42(2):249-53. PubMed ID: 22836862
[TBL] [Abstract][Full Text] [Related]
2. Trends in the use of pre-operative radiation for adenocarcinoma of the pancreas in the United States.
Burke EE; Marmor S; Portschy PR; Virnig BA; Cho LC; Tuttle TM; Jensen EH
HPB (Oxford); 2015 Jun; 17(6):542-50. PubMed ID: 25726950
[TBL] [Abstract][Full Text] [Related]
3. Geographic disparities in surgical treatment recommendation patterns and survival for pancreatic adenocarcinoma.
Salami A; Alvarez NH; Joshi ART
HPB (Oxford); 2017 Nov; 19(11):1008-1015. PubMed ID: 28838634
[TBL] [Abstract][Full Text] [Related]
4. Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer.
Davila JA; Chiao EY; Hasche JC; Petersen NJ; McGlynn KA; Shaib YH
Pancreas; 2009 Jan; 38(1):e18-25. PubMed ID: 18797424
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.
Murphy MM; Simons JP; Hill JS; McDade TP; Chau Ng S; Whalen GF; Shah SA; Harrison LH; Tseng JF
Cancer; 2009 Sep; 115(17):3979-90. PubMed ID: 19514091
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
8. Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy.
Kasumova GG; Eskander MF; de Geus SWL; Neto MM; Tabatabaie O; Ng SC; Miksad RA; Mahadevan A; Rodrigue JR; Tseng JF
Surgery; 2017 Aug; 162(2):275-284. PubMed ID: 28487044
[TBL] [Abstract][Full Text] [Related]
9. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.
Vlacich G; Samson PP; Perkins SM; Roach MC; Parikh PJ; Bradley JD; Lockhart AC; Puri V; Meyers BF; Kozower B; Robinson CG
Cancer Med; 2017 Dec; 6(12):2886-2896. PubMed ID: 29139215
[TBL] [Abstract][Full Text] [Related]
10. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
[TBL] [Abstract][Full Text] [Related]
11. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
[TBL] [Abstract][Full Text] [Related]
12. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
Abdel-Rahman O
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
[TBL] [Abstract][Full Text] [Related]
14. Underuse of surgical resection among elderly patients with early-stage pancreatic cancer.
He W; Zhao H; Chan W; Lopez D; Shroff RT; Giordano SH
Surgery; 2015 Nov; 158(5):1226-34. PubMed ID: 26138347
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
Stessin AM; Meyer JE; Sherr DL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
[TBL] [Abstract][Full Text] [Related]
16. Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity.
Swords DS; Mulvihill SJ; Brooke BS; Skarda DE; Firpo MA; Scaife CL
Surgery; 2019 Apr; 165(4):751-759. PubMed ID: 30551868
[TBL] [Abstract][Full Text] [Related]
17. A multi-institutional study of pancreatic cancer in Harris County, Texas: race predicts treatment and survival.
Wray CJ; Castro-Echeverry E; Silberfein EJ; Ko TC; Kao LS
Ann Surg Oncol; 2012 Sep; 19(9):2776-81. PubMed ID: 22526908
[TBL] [Abstract][Full Text] [Related]
18. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma.
Lee CM; Szabo A; Shrieve DC; Macdonald OK; Gaffney DK
JAMA; 2006 Jan; 295(4):389-97. PubMed ID: 16434629
[TBL] [Abstract][Full Text] [Related]
19. Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma.
Parmar AD; Vargas GM; Tamirisa NP; Sheffield KM; Riall TS
Surgery; 2014 Aug; 156(2):280-9. PubMed ID: 24851723
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.
Singal V; Singal AK; Kuo YF
J Cancer Res Clin Oncol; 2012 Apr; 138(4):715-22. PubMed ID: 22246279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
